🧠💙 May is Huntington's Disease Awareness Month
May 7, 2025
At Pharmidex, we stand in solidarity with individuals and families affected by Huntington’s Disease a rare, inherited neurodegenerative condition that impacts the mind, body, and spirit.
Throughout May, we reaffirm our commitment to advancing neuroscience research and supporting drug discovery efforts aimed at neurodegenerative diseases.
Our team is proud to collaborate with partners working toward meaningful therapies that can improve quality of life and bring hope to the HD community.
Let’s raise awareness. Let’s drive innovation. Let’s stand together.
#HuntingtonsDisease #HDAwarenessMonth #Neuroscience #DrugDiscovery #Pharmidex #RareDiseases #PatientFirst
We are pleased to share that Ian Knowles and Martin Barrett will attend Pharmacology 2025, organized by The British Pharmacological Society (BPS), at the ICC Belfast from 16–18 December 2025. They will host a Pharmidex exhibition stand, showcasing our key services and their importance in drug discovery and development. Ian and Martin will be delighted to meet attendees, exchange ideas, and explore new collaboration opportunities. Come and say hello!
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
